Neuromuscular monitoring in 2024: are we practising to the highest possible standards?

Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on neuromuscular monitoring in 2024. In this first part, Prof Heidi Lewald, Technical University of Munich, Germany, will provide an overview of strategies for reversing neuromuscular block.

This webinar was sponsored by GE HealthCare.

Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on neuromuscular monitoring in 2024. In this second part, Dr. J. Ross Renew MD FASA FASE, Mayo Clinic, Florida, will review the pharmacology of reversal agents discussing their benefits and side-effects.

This webinar was sponsored by GE HealthCare.

Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on neuromuscular monitoring in 2024. In this third part, Prof. Sorin Brull, Mayo Clinic, Florida, will review the latest American and ESAIC guidelines on monitoring neuromuscular block.

This webinar was sponsored by GE HealthCare.

Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on neuromuscular monitoring in 2024. In this fourth part, Dr Pavan Raju, Dundee will discuss the techniques of quantitative neuromuscular monitoring and review the best equipment to use.

This webinar was sponsored by GE HealthCare.

Welcome to this webinar series presented by the Association of Anaesthetists of Great Britain and Ireland on neuromuscular monitoring in 2024. In this last part, listen to the summary of the main messages by Prof Jennie Hunter, questions and discussion.

This webinar was sponsored by GE HealthCare.